Differential Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Sensitivity to Activated Protein C Among Postmenopausal Women

This publication has 28 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors
  Journal of Internal Medicine, 2001
• The Effects of Hormone Replacement Therapy on Hemostatic Variables in Women with Angiographically Verified Coronary Artery Disease: Results from the Estrogen in Women with Atherosclerosis Study
  Thrombosis Research, 2000
• Acquired APC resistance and oral contraceptives: differences between two functional tests
  British Journal of Haematology, 1999
• The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus
  Blood Coagulation & Fibrinolysis, 1999
• Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals
  Blood Coagulation & Fibrinolysis, 1997
• Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
  The Lancet, 1996
• Risk of venous thromboembolism in users of hormone replacement therapy
  The Lancet, 1996
• Prospective study of exogenous hormones and risk of pulmonary embolism in women
  The Lancet, 1996
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994